Mounjaro (tirzepatide), a weight-loss injection, is now approved to treat moderate-to-severe obstructive sleep apnea in obese adults, offering a breakthrough option beyond CPAP therapy, despite ...

Ozempic is known as a drug that treats type 2 diabetes and helps with weight loss, but it may also improve symptoms of sleep apnea. A similar drug called tirzepatide (Zepbound) was approved by the ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

“The egregiously high list prices set by drug manufacturers of GLP-1s for weight loss are the single biggest barrier to patient access,” CVS Health said in a statement.

Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea. The drug demonstrated 20% average ...

The early-stage study suggested a diabetes drug may lower pressure in the brain. Drugs in the same family as Ozempic and Wegovy are known for treating diabetes and helping with weight loss, but a ...

When it comes to weight loss, providers and patients argue that GLP-1 medications are not a one-for-one swap and that volatile insurance coverage contradicts the science and experience of people ...